Form 4 for EW Edwards Lifesciences
Accepted 2026-07-07 18:56:18 ET · period of report 2026-07-07 · accession 0001225208-26-006535 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-07 18:56 | 2026-07-07 | EW | Lippis Daniel J. | CVP, TAVR | F - Tax | $95.18 | -377 | 40.0K | -0.9% | -$35.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-07-07 | F | D | 377 | $95.18 | 40,033.91 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy tax withholding obligations incident to the vesting of securities in accordance with Rule 16b-3(e). |